Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$61,275,284
+$13,867,580 QoQ
Shares Held
51,087
-0.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#495
of 4,601 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOKF, NA holds $220,983,153 across 10 Drug Manufacturers - General names. LLY ranks #1 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
51,087 | $61,275,284 | |
| 2 | ABBV |
AbbVie Inc.
|
194,942 | $49,055,203 | |
| 3 | JNJ |
Johnson & Johnson
|
142,681 | $36,236,693 | |
| 4 | AMGN |
Amgen Inc
|
67,477 | $24,434,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
136,461 | $17,240,482 | |
| 6 | MRK |
Merck & Co., Inc.
|
114,907 | $14,765,549 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
244,226 | $14,072,301 | |
| 8 | PFE |
Pfizer Inc
|
82,045 | $1,975,643 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,275,284 | 51,087 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $47,407,704 | 51,543 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $56,238,008 | 52,330 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $42,899,675 | 56,225 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $44,003,688 | 56,449 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $47,125,598 | 57,059 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $44,264,164 | 57,337 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $51,502,349 | 58,133 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $51,224,589 | 56,578 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $44,404,400 | 57,078 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $33,494,582 | 57,460 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $32,192,886 | 59,935 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,641,545 | 61,072 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $22,210,000 | 64,673 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $25,030,771 | 68,420 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $23,109,177 | 71,468 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $16,245,867 | 50,106 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $14,359,450 | 50,143 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $14,946,539 | 54,111 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $13,002,800 | 56,277 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $14,277,531 | 76,424 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $12,259,978 | 72,613 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $10,827,810 | 73,151 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $8,164,014 | 49,726 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $5,772,693 | 41,614 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||